Oral cannabinoids for spasticity in multiple sclerosis: Will attitude continue to limit use?

Lancet

Volumn 362, Issue 9395, 2003, Pages 1513-

  Metz, Luanne ^a   Page, Stacey ^b  

^a FOOTHILLS HOSPITAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRONABINOL; PLACEBO;

CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG SCREENING; HUMAN; INTERMETHOD COMPARISON; MULTIPLE SCLEROSIS; NOTE; PATIENT SELECTION; PRIORITY JOURNAL; RATING SCALE; SIDE EFFECT; SPASTICITY;

EID: 0242486447     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14776-9     Document Type: Note

References (10)

1. Iversen L. Cannabis and the brain. Brain. 126:2003;1252-1270.
2. Baker D., Pryce G., Croxford J.L., et al. Cannabinoids control spasticity and tremor in multiple sclerosis model. Nature. 404:2000;84-87.
3. Martyn C.N., Illis L.S., Thom J. Nabilone in the treatment of multiple sclerosis. Lancet. 345:1995;579.
4. Petro D.J., Ellenberger C. Treatment of human spasticity with delta-9-tetrahydrocannabinol. J Clin Pharmacol. 21:1981;413S-416S.
5. Ungerleider J.T., Andyrsiak T., Fairbanks L., Ellison G.W., Myers L.W. Delta-9-THC in the treatment of spasticity associated with multiple sclerosis. Adv Alcohol Subst Abuse. 7:1988;39-50.
6. Wade D.T., Robson P., House H., Makela P., Aram J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil. 17:2003;21-29.
7. Killestein J., Hoogervorst E.J.L., Reif M., et al. Safety, tolerability and efficacy of orally administered cannabinoids in multiple sclerosis. Neurology. 58:2002;1404-1407.
8. Page S.A., Verhoef M.J., Stebbins R.A., Metz L.M., Levy J.C. Cannabis use as described by people with multiple sclerosis. Can J Neurol Sci. 30:2003;201-205.
9. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 192:1964;540-542.
10. Hinderer S.R., Gupta S. Functional outcome measures to assess interventions for spasticity. Arch Phys Med Rehabil. 77:1996;1083-1089.